Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments
Introduction. To compare the actual 10-year survival outcomes of early single hepatocellular carcinoma (HCC) patients between 3 first-line treatments: radiofrequency ablation (RFA), surgical resection (SR), or transplantation (LT). Methods. A total of 1255 early single HCC patients retrieved from th...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2021/6638117 |
id |
doaj-9c851280a8d54eb88e21f6cb26e126b5 |
---|---|
record_format |
Article |
spelling |
doaj-9c851280a8d54eb88e21f6cb26e126b52021-06-14T00:17:30ZengHindawi LimitedBioMed Research International2314-61412021-01-01202110.1155/2021/6638117Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different TreatmentsFanyu Meng0Haoyun Zhang1Haiwen Peng2Shichun Lu3Department of Hepatobiliary SurgeryDepartment of Hepatobiliary SurgeryDepartment of Orthopedics SurgeryDepartment of Hepatobiliary SurgeryIntroduction. To compare the actual 10-year survival outcomes of early single hepatocellular carcinoma (HCC) patients between 3 first-line treatments: radiofrequency ablation (RFA), surgical resection (SR), or transplantation (LT). Methods. A total of 1255 early single HCC patients retrieved from the Surveillance Epidemiology and End Results (SEER) database were included. Patients survived ≥10 years, and patients died <10 years were compared. Significant predictors associated with 10-year survival were identified by multivariate logistic regression analysis. The 10-year survival outcomes of 3 treatments were compared using multivariate model risk adjustment and inverse probability of treatment weighted (IPTW) adjustment. Results. Of the 1255 patients, 472 patients underwent SR, 259 patients underwent LT, and 524 patients underwent RFA. 149 patients achieved 10-year survival. Multivariate logistic regression analysis showed that age, race, treatment, and fibrosis score were significant predictors for 10-year survival, and LT had the best advantage of 10-year survival, followed by SR. Comparable 10-year survival outcomes were found between SR and RFA after IPTW. Then, a subgroup analysis was performed based on the tumor size, and the results showed that for ≤50 mm tumor, SR showed no significant advantages over RFA for 10-year survival. Conclusions. Estimates of the observational association of different treatments with 10-year survival are sensitive to the analytic method. LT showed the best outcomes for patients. No significant differences for 10-year survival were found between SR and RFA in the IPTW cohort. Subgroup analysis showed that for >50 mm tumor, SR showed significant advantages over RFA after IPTW.http://dx.doi.org/10.1155/2021/6638117 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Fanyu Meng Haoyun Zhang Haiwen Peng Shichun Lu |
spellingShingle |
Fanyu Meng Haoyun Zhang Haiwen Peng Shichun Lu Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments BioMed Research International |
author_facet |
Fanyu Meng Haoyun Zhang Haiwen Peng Shichun Lu |
author_sort |
Fanyu Meng |
title |
Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments |
title_short |
Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments |
title_full |
Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments |
title_fullStr |
Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments |
title_full_unstemmed |
Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments |
title_sort |
comparison of 10-year survival outcomes for early single hepatocellular carcinoma following different treatments |
publisher |
Hindawi Limited |
series |
BioMed Research International |
issn |
2314-6141 |
publishDate |
2021-01-01 |
description |
Introduction. To compare the actual 10-year survival outcomes of early single hepatocellular carcinoma (HCC) patients between 3 first-line treatments: radiofrequency ablation (RFA), surgical resection (SR), or transplantation (LT). Methods. A total of 1255 early single HCC patients retrieved from the Surveillance Epidemiology and End Results (SEER) database were included. Patients survived ≥10 years, and patients died <10 years were compared. Significant predictors associated with 10-year survival were identified by multivariate logistic regression analysis. The 10-year survival outcomes of 3 treatments were compared using multivariate model risk adjustment and inverse probability of treatment weighted (IPTW) adjustment. Results. Of the 1255 patients, 472 patients underwent SR, 259 patients underwent LT, and 524 patients underwent RFA. 149 patients achieved 10-year survival. Multivariate logistic regression analysis showed that age, race, treatment, and fibrosis score were significant predictors for 10-year survival, and LT had the best advantage of 10-year survival, followed by SR. Comparable 10-year survival outcomes were found between SR and RFA after IPTW. Then, a subgroup analysis was performed based on the tumor size, and the results showed that for ≤50 mm tumor, SR showed no significant advantages over RFA for 10-year survival. Conclusions. Estimates of the observational association of different treatments with 10-year survival are sensitive to the analytic method. LT showed the best outcomes for patients. No significant differences for 10-year survival were found between SR and RFA in the IPTW cohort. Subgroup analysis showed that for >50 mm tumor, SR showed significant advantages over RFA after IPTW. |
url |
http://dx.doi.org/10.1155/2021/6638117 |
work_keys_str_mv |
AT fanyumeng comparisonof10yearsurvivaloutcomesforearlysinglehepatocellularcarcinomafollowingdifferenttreatments AT haoyunzhang comparisonof10yearsurvivaloutcomesforearlysinglehepatocellularcarcinomafollowingdifferenttreatments AT haiwenpeng comparisonof10yearsurvivaloutcomesforearlysinglehepatocellularcarcinomafollowingdifferenttreatments AT shichunlu comparisonof10yearsurvivaloutcomesforearlysinglehepatocellularcarcinomafollowingdifferenttreatments |
_version_ |
1721378833415798784 |